ASHG 2026 has ended. This guide stays up as the record of who was there. Next: ASHG 2027, Oct 26–30, 2027 in Nashville

FinnGen at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

FinnGen at ASHG 2026 in Montréal: Booth 1617.

OrganizationASHG 2026 Attendance
FinnGen
Helsinki, Finland
~40 people
FinnGen builds a large-scale genomic and health-data resource for academic researchers, biopharma partners, drug discovery, and genome medicine.
A FinnGen study identified a genetic marker for blood-pressure drug intolerance, moving personalized hypertension treatment closer to practice.
›
A FinnGen study identified a genetic marker for blood-pressure drug intolerance, moving personalized hypertension treatment closer to practice.
2026-08 · source
Found that polygenic risk scores can identify people at substantially higher risk of glaucoma and faster disease progression.
2026-07 · source
Released Data Freeze 13, expanding its public GWAS resource to 2,755 endpoints across more than 500,000 participants and 21 million variants.
2026-06 · source
Source: company newsroom
Approx. €157M total project budget
›
Figure is the overall FinnGen project budget, not a single-year revenue or funding-round figure.
“~157 M€”
Source: funding announcement
Booth
Exhibiting at Booth 1617
Wed, Oct 219:30am–4:30pmThu, Oct 229:30am–6:15pmFri, Oct 239:30am–4:30pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at FinnGen

Tell us what you sell and we’ll find the people at FinnGen most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction